ID   CSCIi002-A
AC   CVCL_E3TY
SY   niPSC 75.1.c2; niPSC-75.1c2; niPSC HDF75
DR   BioSamples; SAMEA115466178
DR   hPSCreg; CSCIi002-A
RX   PubMed=31708477;
CC   From: Wellcome Trust - MRC Stem Cell Institute, University of Cambridge; Cambridge; United Kingdom.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=31708477; DOI=10.1016/j.stemcr.2019.10.009; PMCID=PMC6915845;
RA   Bredenkamp N., Yang J., Clarke J., Stirparo G.G., von Meyenn F.,
RA   Dietmann S., Baker D.E.C., Drummond R., Ren Y.-M., Li D.-W., Wu C.-M.,
RA   Rostovskaya M., Eminli-Meissner S., Smith A.G., Guo G.;
RT   "Wnt inhibition facilitates RNA-mediated reprogramming of human
RT   somatic cells to naive pluripotency.";
RL   Stem Cell Reports 13:1083-1098(2019).
//